Cancer premiums and latency effects: A risk tradeoff approach for valuing reductions in fatal cancer risks (Q928723): Difference between revisions
From MaRDI portal
Set OpenAlex properties. |
ReferenceBot (talk | contribs) Changed an Item |
||
| Property / cites work | |||
| Property / cites work: Willingness to pay for mortality risk reductions: does latency matter? / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Effects of disease type and latency on the value of mortality risk / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Age, health and the willingness to pay for mortality risk reductions: A contingent valuation survey of Ontario residents / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: A Reference Lottery Metric for Valuing Health / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: A choice experiment approach to the valuation of mortality / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: The value of a statistical life: A critical review of market estimates throughout the world / rank | |||
Normal rank | |||
Latest revision as of 10:46, 28 June 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cancer premiums and latency effects: A risk tradeoff approach for valuing reductions in fatal cancer risks |
scientific article |
Statements
Cancer premiums and latency effects: A risk tradeoff approach for valuing reductions in fatal cancer risks (English)
0 references
11 June 2008
0 references
Value of statistical life
0 references
Cancer risk
0 references
Risk trade-off
0 references
Latency
0 references
